In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B

Journal of Viral Hepatitis

Volumn 15, Issue 6, 2008, Pages 442-448

  Loggi, E ^a   Gramenzi, A ^a   Margotti, M ^a   Cursaro, C ^a   Galli, S ^a   Vitale, G ^a   Grandini, E ^a   Scuteri, A ^a   Vukotic, R ^a   Andreone, P ^a   Bernardi, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Hepatitis B; Immune response; T helper 1; T helper 2; Thymosin alpha 1

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; THYMOSIN ALPHA1;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; HELPER CELL; HEPATITIS B; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TH1 CELL; TH2 CELL; VOLUNTEER;

2',5'-OLIGOADENYLATE SYNTHETASE; ADULT; ANTIVIRAL AGENTS; CELLS, CULTURED; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-2; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; TH1 CELLS; TH2 CELLS; THYMOSIN;

EID: 43549126479     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2007.00960.x     Document Type: Article

References (36)

1. Lok AS, Mc Mahon BJ. Practice Guidelines Committee, American Association for the Study of Liver Diseases, 2001. Chronic hepatitis B. Hepatology 2001 34 : 1225 1241.
2. Villeneuve JP. The natural history of chronic hepatitis B virus infection. J Clin Virol 2005 34 (Suppl. 1 S139 142.
3. Bertoletti A, Gehring AJ. The immune response during hepatitis B virus infection. J Gen Virol 2006 87 : 1439 1449.
4. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995 13 : 29 60.
5. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996 17 : 138 146.
6. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998 8 : 275 283.
7. Ferrari C, Missale G, Boni C, Urbani S. Immunopathogenesis of hepatitis B. J Hepatol 2003 39 (Suppl. 1 S36 42.
8. Akpolat N, Yahsi S, Godekmerdan A, Demirbag K, Yalniz M. Relationship between serum cytokine levels and histopathological changes of liver in patients with hepatitis B. World J Gastroenterol 2005 11 : 3260 3263.
9. Jiang R, Feng X, Guo Y et al. T helper cells in patients with chronic hepatitis B virus infection. Chin Med J (Engl) 2002 115 : 422 424.
10. Li CL, Zhang T, Saibara T et al. Thymosin alpha1 accelerates restoration of T cell-mediated neutralizing antibody response in immunocompromised hosts. Int Immunopharmacol 2002 2 : 39 46.
11. Chien RN, Liaw YF. Thymalfasin for the treatment of chronic hepatitis B. Expert Rev Anti Infect Ther 2004 2 : 9 16.
12. Knutsen AP, Freeman JJ, Mueller KR, Roodman ST, Bouhasin JD. Thymosin-alpha1 stimulates maturation of CD34 + stem cells into CD3 + 4 + cells in an in vitro thymic epithelia organ coculture model. Int J Immunopharmacol 1999 21 : 15 26.
13. Giuliani C, Napolitano G, Mastino A et al. Thymosin-alpha1 regulates MHC class I expression in FRTL-5 cells at transcriptional level. Eur J Immunol 2000 30 : 778 786.
14. Sherman KE, Jones CC, Goldstein AL, Naylor PH. Low thymosin alpha-1 concentrations in patients chronically infected with the hepatitis B virus. Viral Immunol 1991 4 : 195 199.
15. Andreone P, Cursaro C, Gramenzi A et al. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody and hepatitis B virus DNA positive chronic hepatitis B. Hepatology 1996 24 : 774 777.
16. Chien RN, Liaw YF, Chen TC, Yeh CT, Sheen IS. Efficacy of thymosin alpha1 in patients with chronic hepatitis B: a randomized, controlled trial. Hepatology 1998 27 : 383 387.
17. Andreone P, Cursaro C, Gramenzi A et al. In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C. J Viral Hepat 2001 8 : 194 201.
18. Andreone P, Gramenzi A, Loggi E et al. In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C. Cytokine 2004 26 : 95 101.
19. Thomas HC, Montano L, Goodall A et al. Immunological mechanism in chronic hepatitis B virus infection. Hepatology 1982 2 : 116S 121S.
20. Penna A, Artini M, Cavalli A et al. Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest 1996 98 : 1185 1194.
21. Penna A, Del Prete G, Cavalli A et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology 1997 25 : 1022 1027.
22. Rehermann B, Pasquinelli C, Mosier SM, Chisari FV. Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. J Clin Invest 1995 96 : 1527 1534.
23. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996 2 : 1104 1108.
24. Webster GJ, Reignat S, Brown D et al. Longitudinal analysis of CD8 + T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol 2004 78 : 5707 5719.
25. Barnaba V, Franco A, Paroli M et al. Selective expansion of cytotoxic T lymphocytes with a CD4 + CD56 + surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus. J Immunol 1994 152 : 3074 3087.
26. Bertoletti A, Naoumov NV. Translation of immunological knowledge into better treatments of chronic hepatitis B. J Hepatol 2003 39 : 115 124.
27. Serrate SA, Schulof RS, Leondaridis L, Goldstein AL, Sztein MB. Modulation of human natural killer cell cytotoxic activity, lymphokine production, and interleukin 2 receptor expression by thymic hormones. J Immunol 1987 139 : 2338 2343.
28. Chan HL, Tang JL, Tam W, Sung JJ. The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis. Aliment Pharmacol Ther 2001 15 : 1899 1905.
29. Lau GK. Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection. J Gastroenterol Hepatol 2000 15 (Suppl. E46 E52.
30. Hyodo N, Tajimi M, Ugajin T, Nakamura I, Imawari M. Frequencies of interferon-gamma and interleukin-10 secreting cells in peripheral blood mononuclear cells and liver infiltrating lymphocytes in chronic hepatitis B virus infection. Hepatol Res 2003 27 : 109 116.
31. Bertoletti A, D'Elios MM, Boni C et al. Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 1997 12 : 193 199.
32. Guilhot S, Guidotti LG, Chisari FV. Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a posttranscriptional mechanism. J Virol 1993 67 : 7444 7449.
33. Kobayashi K, Ishii M, Igarashi T et al. Profiles of cytokines produced by CD4-positive T lymphocytes stimulated by anti-CD3 antibody in patients with chronic hepatitis C. J Gastroenterol 1998 33 : 500 507.
34. Blackburn SD, Wherry EJ. IL-10, T cell exhaustion and viral persistence. Trends Microbiol 2007 15 : 143 146.
35. Milich DR, Chen MK, Hughes JL, Jones JE. The secreted precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J Immunol 1998 160 : 2013 2021.
36. Boni C, Penna A, Bertoletti A et al. Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B. J Hepatol 2003 39 : 595 6.